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108 Only a subset of Pseudomonas aeruginosa strains is able to
colonize CF patients
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Analysis of 200 Pseudomonas aeruginosa strains isolated in 25 countries between
1881 and 2005 and including 40 CF isolates and 7 epidemic CF clones from
5 countries, was carried out. The following tests were performed: fAFLP, serotyping,
PCR of 9 household genes and 23 antibiotic resistance genes, and antibiotic sus-
ceptibility testing for 21 antibiotics. Thirty-ﬁve of the 40 CF isolates, including the
7 epidemic clones, clustered into a clonal complex, also containing environmental
isolates. Most CF isolates exhibited resistance towards important antibiotics, but
without detectable known antibiotic resistance genes. The oprD DNA sequences of
38 CF isolates belonged to one distinct cluster. All CF isolates carried the exoS
gene. The CF clonal complex showed considerable overall genetic diversity, but
also comprised several homogeneous subgroups. We suggest that the CF clonal
complex is overall very successful and therefore more prevalent in the patient
population, with a predisposition for the CF lung. This indicates that only a subset
of P. aeruginosa isolates predisposes to colonization of the CF lung: whereas most
P. aeruginosa can initially be present in the CF lung, only a subset can initiate
permanent colonization. An oprD speciﬁc PCR was evaluated for its value with
regard to the prediction of the colonization potential of different P. aeruginosa
strains.
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For a total of 140 patients which were cultured for P. aeruginosa (PA), A.
xylosoxidans (AX) and S. maltophilia (SM), respectively 70, 26 and 51 patients
were found positive. Genotyping was carried out with ERIC2-PCR and AFLP-
analysis for PA and with (GTG)5-PCR for AX and SM. Two patients carried 3 SM
genotypes, three carried two PA, three two AX and nine two SM genotypes. Six
small PA clusters (one of four, three of three and two of two patients) were observed
and a single large AX cluster, comprising 7 patients. For SM, three clusters were
observed comprising 4, 3 and 3 patients. One patient (G21) carried both a cluster
PA and a cluster AX isolate and another patient (G109) carried both a cluster AX
and a cluster SM isolate. However, there was no concordance between PA, AX and
SM clusters. Overall, cross contamination with strains of PA, AX and SM was very
low within our CF-centre patient population.
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Background: The means by which PA is acquired by CF pts are not yet fully
elucidated. Aim. Address the type of transmission and/or environmental acquisition
of PA and deﬁne if epidemic strains are circulating in Italy.
Methods: A collection of 340 strains from 183 pts attending 4 CF centres located
in north (A), centre (B) and south Italy (C and D), and 50 environmental (11 from
hospital sinks, 39 from swimming pool and mineral water) were genotyped by
BOX-PCR (Rademarker J.L.W et al. 1998). A PA panel control strains included:
PA01, ATCC 27853, European clone C (EC), Manchester Epidemic Strain (MES)
and Liverpool Epidemic Strain (LES). The cluster analysis was performed by “Gel
Compar II”.
Resuts: A total of 179 genotypes were found. 132 pts were colonized with a
single PA genotype, and 46 with two o more genotypes. A total of 82 pts showed
genotyped “shared” with other pts while 86 pts had “unique” genotype. 36 groups
of pts carrying the same genotype (clusters) were observed: 22 of 2 pts size, 7
of 3 pts, 5 of 4 pts and 2 of 5 pts. No Italian PA CF Strains showed genetically
correlation with EC, LES and MES. No genetically correlation was observed
between environmental and CF strains. No genotypes correlated were found among
strains from Centres A, B and C. 3 genotypes found in 3 pts of centre B are highly
correlated with 3 genotypes found in 2 pts of centre D.
Conclusions: The signiﬁcant number of cluster found recognized the importance
of the person-to-person transmission in the centres examined. Environmental ac-
quisition was not documented.
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Chronic infection with Pseudomonas aeruginosa is associated with a decline in
clinical status of cystic ﬁbrosis (CF) patients. Some studies have shown that a rise
in antibodies to P. aeruginosa is the risk factor most associated with the development
of chronic infection and this increase may detect infection 6−12 months prior to
patients being culture positive. Early detection of the organism and aggressive
antibiotic treatment is beneﬁcial to CF patients and delays the onset of chronic
lung infection.
We have previously described an ELISA system employing A-band LPS as the
antigen. This test has now been further optimised to discriminate IgM and IgG
classed antibodies. We have used this tool to analyse retrospectively 394 serum
samples from 22 patients dating back to 1992. These results have been correlated
with the patients’ microbiological and clinical data. The mean age of the ﬁrst
P. aeruginosa isolated from sputum was 5.8 years. Fourteen of the 22 patients
provided serum samples prior to the ﬁrst recovery of pseudomonas from respiratory
specimens. Of these, 4 (18%) demonstrated elevated antibody titres to A-band LPS
before culture positivity. Data validating the ELISA will be presented addressing
changes of titres over time, categorisation of degree of antibody response, with
comparisons to immunoblots and lung function results. We suggest that regular
monitoring of serum antibodies to P. aeruginosa using A-band LPS as the target
antigen has great potential for the diagnosis of infection in CF patients.
